Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors
Autor: | Jeonghwan Youk, M Shin, Sang A. Kim, Hyewon Lee, Jayoun Lee, June-Won Cheong, Youngil Koh, Minjoo Kang, Sang Jin Shin, Joon Ho Moon, Yeonjoo Choi, Junho Jang |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Male medicine.medical_specialty Databases Factual medicine.medical_treatment education Population Human leukocyte antigen Hematopoietic stem cell transplantation Disease Disease-Free Survival 03 medical and health sciences 0302 clinical medicine Internal medicine Republic of Korea medicine Humans Survival rate Retrospective Studies education.field_of_study Hematology business.industry Incidence Incidence (epidemiology) Hematopoietic Stem Cell Transplantation Retrospective cohort study General Medicine Middle Aged Survival Rate Hematologic Neoplasms 030220 oncology & carcinogenesis Female Unrelated Donors business Follow-Up Studies 030215 immunology |
Zdroj: | Annals of Hematology. 98:501-510 |
ISSN: | 1432-0584 0939-5555 |
DOI: | 10.1007/s00277-018-3550-z |
Popis: | The advent of various alternative donors in allogeneic hematopoietic stem cell transplantation (HSCT) raises the question of using international donors, especially in ethnically homogenous populations. We analyzed the clinical outcome and medical expense of human leukocyte antigen (HLA)-matched HSCT using domestic and international donors. We analyzed the patients who received allogeneic HSCT at five medical centers in Korea in the last 10 years. Using propensity-score matching, we compared overall survival (OS), relapse-free survival (RFS), and transplantation-related complications. Medical expense was analyzed based on National Health Insurance Service (NHIS) data. A total of 269 patients were analyzed after 3:1 (domestic/international) matching. There was no difference in OS (p = 0.395) and RFS (p = 0.604) between the domestic and international donor groups (5-year OS rate 42.9 and 37.8%, 5-year RFS rate 37.6 and 33.5% for domestic and international groups, respectively). No difference in chronic graft-versus-host disease (GVHD) incidence was observed (34.2% in domestic and 35.9% in international group, p = 0.804). Early infection was more frequent in the domestic group (55.0 vs. 35.8%, p = 0.007), whereas infection after 30 days was more frequent in the international group (28.7 vs. 49.3%, p = 0.001). Mean medical expense was far higher in the international group, by US $51,944 in the entire follow-up period (p |
Databáze: | OpenAIRE |
Externí odkaz: |